Amer Bio Return On Asset vs. Operating Margin

ABMCDelisted Stock  USD 0.01  0  38.00%   
Considering Amer Bio's profitability and operating efficiency indicators, Amer Bio Medica may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Amer Bio's ability to earn profits and add value for shareholders.
For Amer Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amer Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amer Bio Medica utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amer Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amer Bio Medica over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please note, there is a significant difference between Amer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Amer Bio Medica Operating Margin vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Amer Bio's current stock value. Our valuation model uses many indicators to compare Amer Bio value to that of its competitors to determine the firm's financial worth.
Amer Bio Medica is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amer Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amer Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Amer Operating Margin vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Amer Bio

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.42
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Amer Bio

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(0.93) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Amer Operating Margin Comparison

Amer Bio is currently under evaluation in operating margin category among its peers.

Amer Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Amer Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amer Bio will eventually generate negative long term returns. The profitability progress is the general direction of Amer Bio's change in net profit over the period of time. It can combine multiple indicators of Amer Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.

Amer Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Amer Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amer Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amer Bio's important profitability drivers and their relationship over time.

Use Amer Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Bio will appreciate offsetting losses from the drop in the long position's value.

Amer Bio Pair Trading

Amer Bio Medica Pair Trading Analysis

The ability to find closely correlated positions to Amer Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amer Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amer Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amer Bio Medica to buy it.
The correlation of Amer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amer Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amer Bio Medica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amer Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Amer Bio position

In addition to having Amer Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Size And Style ETFs Thematic Idea Now

Size And Style ETFs
Size And Style ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Size And Style ETFs theme has 1091 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Size And Style ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Amer Pink Sheet

If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA